We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative...
$10,000 scholarship to be awarded to a rising junior with a life science major attending a Pennsylvania-based four-year college or university Scholarship application deadline is April 26 for the...
Continued momentum in upliFT-D trial of PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin mutations (GRN) with clinical trial site expansion into Europe and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0699 | 5.825 | 1.2 | 1.28 | 1.1006 | 93711 | 1.16598339 | CS |
4 | -0.0901 | -6.625 | 1.36 | 1.45 | 1.1006 | 132110 | 1.29667887 | CS |
12 | 0.2999 | 30.9175257732 | 0.97 | 1.79 | 0.9381 | 364492 | 1.39032421 | CS |
26 | 0.5999 | 89.5373134328 | 0.67 | 1.79 | 0.5751 | 500814 | 1.00836436 | CS |
52 | 0.2799 | 28.2727272727 | 0.99 | 1.79 | 0.5751 | 353387 | 0.96520529 | CS |
156 | -15.6701 | -92.5035419126 | 16.94 | 19.84 | 0.5751 | 331625 | 4.0548068 | CS |
260 | -21.0001 | -94.2977099237 | 22.27 | 38.23 | 0.5751 | 316208 | 8.09355597 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions